Mark Vignola, Ph.D.
Equibles does not estimate personal net worth.
Get an email with a short summary when Korsana Biosciences, Inc. publishes a filing, an earnings call transcript or a press release.
Get KRSA alertsAbout Mark Vignola, Ph.D.
Mark Vignola, Ph.D. is recorded as CFO at Korsana Biosciences, Inc. (KRSA) since September 8, 2026. Korsana Biosciences, Inc. reported in an 8-K filed September 11, 2026 that Mark Vignola, Ph.D. was appointed Chief Financial Officer, effective September 8, 2026. Korsana Biosciences, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Korsana Biosciences, Inc. includes Jonathan Violin, Ph.D. (CEO and Board Member), Regina M. Graul (CEO and Board Member), Tomas Kiselak (Chairman and Board Member) and 7 others.
“On September 8, 2026, the Board appointed Jonathan Violin, Ph.D. as the Company’s Chief Executive Officer and President, Mark Vignola, Ph.D. as the Company’s Chief Financial Officer and Matthew Leoni, M.D. as the Company’s Chief Medical Officer, each to serve at the discretion of the Board.”
Affiliation history
-
Current
2026-09-08–present
Company network
Leadership on record at Korsana Biosciences, Inc.
- Jonathan Violin, Ph.D. CEO, Board Member
- Regina M. Graul CEO, Board Member
- Tomas Kiselak Chairman, Board Member
- Anjeza Gjino CFO
- Peter M. Hecht CFO, Board Member
- Andrew Gottesdiener Board Member
- Andrew Gottesdiener, M.D. Board Member
- Dina Katabi Board Member
- Dina Katabi, Ph.D. Board Member
- Heidi Henson Board Member